Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts

Circulation

Volumn 94, Issue 4, 1996, Pages 742-747

  Zaugg, Christian E ^a   Hornstein, Pius S ^a   Zhu, Peili ^a   Simper, David ^a   Lüscher, Thomas F ^b   Allegrini, Peter R ^c   Buser, Peter T ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CIBA GEIGY LTD   (Switzerland)

Author keywords

endothelin; ischemia; reperfusion; thromboxane; vasoconstriction

Indexed keywords

7 [3 [(2 HEPTANAMIDOACETAMIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CREATINE PHOSPHATE; ENDOTHELIN 1; INDOMETACIN; THROMBOXANE A2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PH; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME IMMUNOASSAY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOLATED HEART; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 0029781393     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.742     Document Type: Article

References (29)

1. Brunner F, du-Toit EF, Opie LH. Endothelin release during ischemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol. 1992;24:1291-1305.
2. Tsuji S, Sawamura A, Watanabe H, Takihara K, Park SE, Azuma J. Plasma endothelin levels during myocardial ischemia and reperfusion. Life Sci. 1991;48:1745-1749.
3. Velasco CE, Turner M, Inagami T, Atkinson JB, Virmani R, Jackson EK, Murray JJ, Forman MB. Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am Heart J. 1994;128:441-451.
4. McMurdo L, Sessa WC, Thiemermann C, Vane JR. Ischaemia and reperfusion injury potentiates the vasoconstrictor effects of endothelin-1 in the isolated perfused heart of the rat. Br J Pharmacol. 1991;104:323P. Abstract.
5. Linz W, Albus U, Scholkens BA. Effects of endothelin on isolated ischaemic rat hearts during ramiprilat, bradykinin and indomethacin perfusion. J Hypertens. 1989;7(suppl):S310-S311.
6. Neubauer S, Zimmermann S, Hirsch A, Pulzer F, Tian R, Bauer W, Bauer B, Ertl G. Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol. 1991;23:1397-1409.
7. Saito T, Fushimi E, Abe T, Kimura Y, Takahashi K, Kudo Y, Nakagomi A, Miura M. Augmented contractile response to endothelin and blunted endothelium-dependent relaxation in post-ischemic reperfused coronary arteries. Jpn Circ J. 1992;56:657-670.
8. Zaugg CE, Zhu P, Simper D, Lüscher TF, Allegrini PR, Buser PT. Differential effects of endothelin-1 on normal and postischemic reperfused myocardium. J Cardiovasc Pharmacol. 1993;22:S367-S370.
9. 125I-labeled endothelin-1 binding in rat cardiac membranes. Am J Physiol. 1990;258:H829-H835.
10. 2 biosynthesis in rat vascular smooth muscle cells. Biochem Pharmacol. 1990;40:2713-2717.
11. Fiedler VB. Role of arachidonic acid metabolites in cardiac ischemia and reperfusion injury. Pharmacotherapy. 1988;8:158-168.
12. 31P-MRS study. Circ Res. 1990;66:735-746.
13. Randall RW, Eakins KE, Higgs GA, Salmon JA, Tateson JE. Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Agents Actions. 1994;43:176-178.
14. Zhu P, Zaugg CE, Simper D, Hornstein P, Allegrini P, Buser PT. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin. Cardiovasc Res. 1995;29:658-663.
15. 2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 1988;12:701-709.
16. 2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditions. Pharmacology. 1990;41:1-15.
17. Küng CF, Lüscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 1995;25:194-200.
18. Kundu GC, Wilson IB. Endothelin-converting enzyme: the binding of metal ions. Int J Pept Protein Res. 1993;42:64-67.
19. Yano M, Okada K, Takada J, Hioki Y, Matsuyama K, Fukuroda T, Noguchi K, Nishikibe M, Ikemoto F. Endothelin-converting enzyme and its in vitro and in vivo inhibition. J Cardiovasc Pharmacol. 1991;17:S26-S28.
20. Ashizawa N, Okumura H, Kobayashi F, Aotsuka T, Asakura R, Arai K, Ashikawa N, Matsuura A. Inhibitory activities of metal chelators on endothelin-converting enzyme, II: in vivo studies. Biol Pharm Bull. 1994;17:212-216.
21. Ashizawa N, Okumura H, Kobayashi F, Aotsuka T, Takahashi M, Asakura R, Arai K, Matsuura A. Inhibitory activities of metal chelators on endothelin-converting enzyme, I: in vitro studies. Biol Pharm Bull. 1994;17:207-211.
22. Okada K, Miyazaki Y, Takada J, Matsuyama K, Yamaki T, Yano M. Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells. Biochem Biophys Res Commun. 1990;171:1192-1198.
23. Gaddian DG, Radda GK, Richards CB, Seeley PJ. Biological Application of Magnetic Resonance. New York, NY: Academic Press Inc; 1979.
24. Katz AN. Physiology of the Heart. New York, NY: Raven Press; 1992:609-637.
25. 2. J Heart Failure. 1995;2:663. Abstract.
26. Taddei S, Vanhoutte PM. Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension. 1993;21:9-15.
27. Lüscher TF, Boulanger CM, Dohi Y, Yang ZH. Endothelium-derived contracting factors. Hypertension. 1992;19:117-130.
28. Lewy IR, Wiener L, Walinsky P, Lefer AM, Silver MJ, Smith JB. Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation. 1980;61:1165-1171.
29. 2. Fed Proc. 1987;46:133-138.